Skip to content

Effect of nutrition formula continuing dietary fiber MT-001 on intestinal flora.

Effect of nutrition formula continuing dietary fiber MT-001 on intestinal flora. - Effect of nutrition formula continuing dietary fiber MT-001 on intestinal flora.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027059
Enrollment
10
Registered
2017-04-19
Start date
2017-04-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eating disorder and dysphagia

Interventions

Supplementation:Test nutrition fomula containing of dietary fiber is administered by tube feeding at three times daily (morning.day.night) Period:28 days after post operative period.

Sponsors

Mejiro Second General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient with tube feeding for eating disorder and malnutrition in hospital

Exclusion criteria

Exclusion criteria: 1) With complications 2) TPN implementation cases 3) It becomes a clinical problem have an infection 4) Patients with respiratory failure 5) Patients with antimicrobial 6) eGFR stage 4 or less 7) Patients with severe liver dysfunction 8) Patients with diabetes 9) Patients with allergy for nutrition formula continuing dietary fiber MT-001. 10) Patients with previous hypersensitivity for nutrition formula continuing dietary fiber MT-001. 11) Previously used nutrition formula continuing dietary fiber MT-001/MT-002. 12) Patients with supplementation contaning dietary fiber 13) Research doctor is determined that inappropriate

Design outcomes

Primary

MeasureTime frame
Fecal Microbiota

Secondary

MeasureTime frame
Short-chain fatty acid analyses Feces pH Physical examination Plasma biochemical analyses

Countries

Japan

Contacts

Public ContactHideaki Mizuno

Mejiro Second General Hospital Department of Surgery

zbm05143@sky.zero.ad.jp042-553-3511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026